Meta menu:

From here, you can access the Emergencies page, Contact Us page, Accessibility Settings, Language Selection, and Search page.

Open Menu

About the CCR

The CCR is a research center that springs out of the Departments of Pharmacology and Toxicology, Cardiology, Nephrology, Physiology, Endocrinology and Clinical Hypertension Research of the Charité and is well embedded in the scientific landscape of the Charité with close connections between clinical and basic science departments.

You are here:

The interdisciplinary CCR is something quite new in German research for cardiovascular diseases. This fresh impetus in research will not only advance university science, it will open up new avenues of cooperation between the university, the Max-Planck society and the pharmaceutical industry. The aim of the center is to find new approaches for the pathophysiological understanding and treatment of common diseases of hypertension, obesity, heart failure and stroke.
The CCR, which started its work in October 2003 with a festive scientific symposium is part of Berlins cross-campus network for research into circulatory disorders at the Charité - Universitätsmedizin Berlin. More than 200 scientists, PhD students and associates in 23 independent groups from different research areas i.e. pharmacology, cardiology/angiology, nephrology, clinical hypertension research and molecular biology have moved into the center in order to be able to work together on scientific themes relating to the cardiovascular system. They are joined together by many ties in terms of contents and structure including joint research projects subsidised by the DFG (German Society for the Advancement of Scientific Research), the BMBF (Federal Ministry of Education and Research), the European Union and other external funding providers in Germany and abroad. The scientific emphasis is on themes such as hypertension, obesity, diabetes mellitus, stroke, cardiomyopathies, gender research and molecular genetics of cardiovascular disorders and development of drugs within the cardiovascular-metabolic range.